These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19705343)

  • 1. FX-06, a fibrin-derived Bbeta15-42 peptide for the potential treatment of reperfusion injury following myocardial infarction.
    Ahrens I; Peter K
    Curr Opin Investig Drugs; 2009 Sep; 10(9):997-1003. PubMed ID: 19705343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury.
    Petzelbauer P; Zacharowski PA; Miyazaki Y; Friedl P; Wickenhauser G; Castellino FJ; Gröger M; Wolff K; Zacharowski K
    Nat Med; 2005 Mar; 11(3):298-304. PubMed ID: 15723073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fibrin-derived peptide Bbeta15-42 is cardioprotective in a pig model of myocardial ischemia-reperfusion injury.
    Roesner JP; Petzelbauer P; Koch A; Mersmann J; Zacharowski PA; Boehm O; Reingruber S; Pasteiner W; Mascher D; Wolzt M; Barthuber C; Nöldge-Schomburg GE; Scheeren TW; Zacharowski K
    Crit Care Med; 2007 Jul; 35(7):1730-5. PubMed ID: 17522584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derived peptide Bbeta(15-42)) on ischemia-reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Atar D; Huber K; Rupprecht HJ; Kopecky SL; Schwitter J; Theek C; Brandl K; Henning R; Geudelin B
    Cardiology; 2007; 108(2):117-23. PubMed ID: 17019083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.
    Atar D; Petzelbauer P; Schwitter J; Huber K; Rensing B; Kasprzak JD; Butter C; Grip L; Hansen PR; Süselbeck T; Clemmensen PM; Marin-Galiano M; Geudelin B; Buser PT;
    J Am Coll Cardiol; 2009 Feb; 53(8):720-9. PubMed ID: 19232907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial reperfusion injury and the challenging quest for its prevention.
    Merx MW; Kelm M
    Crit Care Med; 2007 Jul; 35(7):1793-4. PubMed ID: 17581372
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemorrhagic shock and reperfusion injury: the critical interplay of fibrin fragments, leukocytes, and vascular endothelial-cadherin.
    Beishuizen A; Girbes AR
    Crit Care Med; 2009 Feb; 37(2):771-2. PubMed ID: 19325382
    [No Abstract]   [Full Text] [Related]  

  • 8. Bbeta15-42 (FX06) reduces pulmonary, myocardial, liver, and small intestine damage in a pig model of hemorrhagic shock and reperfusion.
    Roesner JP; Petzelbauer P; Koch A; Tran N; Iber T; Vagts DA; Scheeren TW; Vollmar B; Nöldge-Schomburg GE; Zacharowski K
    Crit Care Med; 2009 Feb; 37(2):598-605. PubMed ID: 19114899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined peri-ischemic administration of Bβ15-42 in treating ischemia reperfusion injury of the mouse kidney.
    Urbschat A; Rupprecht K; Zacharowski K; Obermüller N; Scheller B; Holfeld J; Tepeköylü C; Hofmann R; Paulus P
    Microvasc Res; 2015 Sep; 101():48-54. PubMed ID: 26116861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The small fibrinopeptide Bβ15-42 as renoprotective agent preserving the endothelial and vascular integrity in early ischemia reperfusion injury in the mouse kidney.
    Urbschat A; Zacharowski K; Obermüller N; Rupprecht K; Penzkofer D; Jennewein C; Tran N; Scheller B; Dimmeler S; Paulus P
    PLoS One; 2014; 9(1):e84432. PubMed ID: 24392138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of fibrin with VE-cadherin and anti-inflammatory effect of fibrin-derived fragments.
    Yakovlev S; Gao Y; Cao C; Chen L; Strickland DK; Zhang L; Medved L
    J Thromb Haemost; 2011 Sep; 9(9):1847-55. PubMed ID: 21752185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging drugs for acute myocardial infarction.
    Lazzeri C; Tarquini R; Valente S; Abbate R; Gensini GF
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):87-105. PubMed ID: 20055689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting the "fire" of myocardial reperfusion injury: how to define success?
    Wu KC
    J Am Coll Cardiol; 2009 Feb; 53(8):730-1. PubMed ID: 19232908
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of the fibrin-derived peptide Bbeta(15-42) in acute and chronic rodent models of myocardial ischemia-reperfusion.
    Zacharowski K; Zacharowski PA; Friedl P; Mastan P; Koch A; Boehm O; Rother RP; Reingruber S; Henning R; Emeis JJ; Petzelbauer P
    Shock; 2007 Jun; 27(6):631-7. PubMed ID: 17505302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fibrin-derived peptide bβ15-42 attenuates liver damage in a rat model of liver ischemia/reperfusion injury.
    Liu A; Fang H; Yang Y; Sun J; Fan H; Liu S; Dirsch O; Dahmen U
    Shock; 2013 Apr; 39(4):397-403. PubMed ID: 23503399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.
    Dirksen MT; Laarman GJ; Simoons ML; Duncker DJ
    Cardiovasc Res; 2007 Jun; 74(3):343-55. PubMed ID: 17306241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction.
    De Luca G; Cassetti E; Marino P
    Am J Emerg Med; 2009 Jul; 27(6):712-9. PubMed ID: 19751630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide Bbeta(15-42) preserves endothelial barrier function in shock.
    Gröger M; Pasteiner W; Ignatyev G; Matt U; Knapp S; Atrasheuskaya A; Bukin E; Friedl P; Zinkl D; Hofer-Warbinek R; Zacharowski K; Petzelbauer P; Reingruber S
    PLoS One; 2009; 4(4):e5391. PubMed ID: 19401765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a vascular endothelial cadherin antagonist in a rat lung transplant model.
    Tian Z; Dong B; Blackwell JW; Stewart PW; Egan TM
    Ann Thorac Surg; 2013 Mar; 95(3):1028-33. PubMed ID: 23333062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U;
    Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.